ETFs most similar to BIB
The funds whose holdings overlap ProShares Ultra NASDAQ Biotechnology the most, by weight. as of Oct 21, 2026issuer data
By holdings overlap
| Fund | Category | Overlap with BIB | Fee | Assets | 1Y | Yield | Compare |
|---|---|---|---|---|---|---|---|
| BIBProShares Ultra NASDAQ Biotechnology | Leveraged Equity | — | 0.95% | $96M | +66.7% | 0.20% | |
| IBBQInvesco Nasdaq Biotechnology ETF | Biotech & Health Innovation | 58% | 0.19% | $67M | +34.5% | 1.11% | side by side |
| IBBiShares Biotechnology ETF | Biotech & Health Innovation | 55% | 0.44% | $11.0B | +35.2% | 0.16% | side by side |
| BBHVanEck Biotech ETF | Biotech & Health Innovation | 35% | 0.35% | $507M | +39.8% | 0.38% | side by side |
| XBIState Street SPDR S&P Biotech ETF | Biotech & Health Innovation | 32% | 0.35% | $10.4B | +38.7% | 0.36% | side by side |
| FTXHFirst Trust Nasdaq Pharmaceuticals ETF | Health Care | 31% | 0.60% | $1.1B | +45.4% | 0.68% | side by side |
Overlap is the sum of the smaller of the two weights across every shared holding. Try any combination in the overlap tool.
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.